Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03868891
Other study ID # PRO18110061
Secondary ID 5R21DC017553-02
Status Terminated
Phase N/A
First received
Last updated
Start date August 16, 2019
Est. completion date May 31, 2022

Study information

Verified date May 2023
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Elevation of the soft palate (the soft part of the roof of the mouth) during swallowing helps the Eustachian tube to open and keep the ear healthy. (The Eustachian tube is the normal tube running from the middle ear to the back of the nose and throat). When the soft palate does not move enough (due to a history of cleft palate or for unknown reasons), this can lead to speech problems. Also, because the Eustachian tube is not opening enough, fluid can accumulate in the middle ear, which requires treatment with ear tubes. The goal of this research study is to determine if soft palate exercises will help improve the ability of the soft palate to close the area between the throat and nose, like it is supposed to during speech and swallowing, and if this improves Eustachian tube opening.


Description:

This trial will look at the feasibility and effect of device-assisted soft palate exercises for the treatment of chronic Eustachian tube (ET) dysfunction (ETD) in older children still experiencing middle-ear disease. Children with or without cleft palate (CP) with ventilation tubes (VTs) will be evaluated for the function of the soft palate and the ET. Subjects with active muscular ETD and inadequate soft palate closure will be prescribed soft palate strengthening exercises for at least 2 months. The objective of the study is to demonstrate the effect of exercises on soft palate closure and ETF. This pilot study will enroll 30 children between ages 6-17 years with VTs or post-VT extrusion tympanic membrane (TM) perforations. All 30 children will have ETD, with active muscular dysfunction. 15 subjects will have a history of cleft palate (CP) and 15 no history of CP. Subjects will undergo history, physical examination including an ENT exam, video-otoscopy and ET function testing which may include Forced Response Test (FRT), Inflation-Deflation Test (IDT) and Tubomanometry. They will also undergo evaluations for swallow, speech and soft palate function. Enrolled children will then receive instruction on the use their EMST150 exercise device. This device will be used daily for at least 2 months. Subjects will undergo full evaluations for ET function and velopharyngeal incompetence after the 2-month treatment and will then discontinue the use of devices for at least 2 months. After this time, the same testing will be done. Weekly phone calls/emails/texts from study staff will encourage use of the devices as prescribed. The following secondary outcome measures were part of the original study protocol but were eliminated after the start of the COVID-19 pandemic because the tests involved blowing maneuvers and risk of aerosolization. The protocol was modified to only include ETF tests that were necessary to achieve the goals of the study and that were safe for the participants. 'Velopharyngeal pressure after 2 months of exercise compared with baseline' 'Velopharyngeal pressure after 2 months of rest compared with baseline' 'Duration of velopharyngeal closure after 2 months of exercise compared with baseline' 'Duration of velopharyngeal closure after 2 months of rest compared with baseline' 'Ability to maintain velopharyngeal closure after 2 months of exercise compared with baseline' 'Ability to maintain velopharyngeal closure after 2 months of rest compared with baseline' 'Overall success in velopharyngeal closure after 2 months of exercise compared with baseline' 'Overall success in velopharyngeal closure following 2 months of rest compared with baseline' The following other pre-specified outcome measures were removed for the same reason: 'Velopharyngeal pressure after 2 months of rest compared with pressure immediately following 2 months of exercise' 'Duration of velopharyngeal closure after 2 months of rest compared with pressure immediately following 2 months of exercise' 'Ability to maintain velopharyngeal closure after 2 months of rest compared with ability immediately following 2 months of exercise' 'Overall success in velopharyngeal closure following 2 months of rest compared with success immediately following 2 months of exercise' 'Eustachian tube function after 2 months of rest compared with function immediately following 2 months of exercise' was moved from an other pre-specified outcome measure to a secondary outcome measure due to its similar level of importance to the other secondary outcome measures. Pressure chamber results were removed from outcome measures because they were unable to be obtained safely during the COVID-19 pandemic.


Recruitment information / eligibility

Status Terminated
Enrollment 11
Est. completion date May 31, 2022
Est. primary completion date April 6, 2022
Accepts healthy volunteers No
Gender All
Age group 6 Years to 17 Years
Eligibility Inclusion Criteria: - 6-17 years old - Otherwise healthy - Currently have unilateral or bilateral ventilation tube(s) (VTs) inserted for otitis media with effusion (OME) or tympanic membrane retraction/retraction pocket (TM-R/RP) or a TM perforation after extrusion of a VT - History of at least 2 sets of VT insertions in the past - Eustachian tube (ET) function (ETF) tests showing an active muscular pattern of Eustachian tube dysfunction - Some degree of velopharyngeal dysfunction during the ETF tests - Cleft Palate (CP) cohort: non-syndromic; prior palatoplasty without complications or need for revision - Non-CP cohort: have had prior adenoidectomy Exclusion Criteria: - Concurrent or past diagnosis of cancer or history of radiation - Have or had vestibular pathology, cranial base surgery or ossicular chain reconstruction - Craniofacial dysmorphology (other than non-syndromic CP with or without cleft lip in the CP cohort) or other syndrome - A non-patent nasal cavity - Patulous ET or pathologically low ET opening or closing pressures - Unable or unwilling to perform the tests and exercises outlined in the study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
EMST150
The EMST150 consists of a handheld plastic tube with a mouthpiece on one end and an adjustable valve on the other end. Your child will close his/her lips around the mouthpiece and breathe out against resistance. The EMST150 will be adjusted to the point where airflow stops. Each day, your child will blow into the EMST150 5 sets of 5 times with a 10-15 second rest between each use and a 1-2 minute rest between each set of 5. You will adjust the resistance of the device each week, take a picture of the device settings, and document exercise sets performed in an exercise diary. These exercises will be performed twice in each nostril 2 times a day until your child's next visit at the MEPL (at least 8 weeks). Each session should take approximately 10-15 minutes, for a total of 30 minutes per day.

Locations

Country Name City State
United States UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Noel Jabbour National Institute on Deafness and Other Communication Disorders (NIDCD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Signs of Submucous Cleft Palate Following 2 Months of Exercise Compared With Baseline Presence or absence of dimpling anterior to the uvula, soft palate vaulting, midline groove, translucent midline, or visible notch in posterior hard palate observed on palate activation during video-analysis Baseline and 2 months
Other Signs of Submucous Cleft Palate Following 2 Months of Rest Compared With Baseline Presence or absence of dimpling anterior to the uvula, soft palate vaulting, midline groove, translucent midline, or visible notch in posterior hard palate observed on palate activation during video-analysis Baseline and 4 months
Other Signs of Submucous Cleft Palate Following 2 Months of Rest Compared With Immediately Following 2 Months of Exercise Presence or absence of dimpling anterior to the uvula, soft palate vaulting, midline groove, translucent midline, or visible notch in posterior hard palate observed on palate activation during video-analysis 2 months and 4 months
Other Perceptual Speech Symptoms of Velopharyngeal Dysfunction Following 2 Months of Exercise Compared With Baseline Perceptual symptoms of velopharyngeal incompetence measured using the Pittsburgh Weighted Speech Score, on a scale of 0-23, with =7 indicating likely velopharyngeal incompetence Baseline and 2 months
Other Perceptual Speech Symptoms of Velopharyngeal Dysfunction Following 2 Months of Rest Compared With Baseline Perceptual symptoms of velopharyngeal incompetence measured using the Pittsburgh Weighted Speech Score, on a scale of 0-23, with =7 indicating likely velopharyngeal incompetence Baseline and 4 months
Other Perceptual Speech Symptoms of Velopharyngeal Dysfunction Following 2 Months of Rest Compared With Immediately Following 2 Months of Exercise Perceptual symptoms of velopharyngeal incompetence measured using the Pittsburgh Weighted Speech Score, on a scale of 0-23, with =7 indicating likely velopharyngeal incompetence 2 months and 4 months
Other Eustachian Tube Function Observed During Maneuvers Following 2 Months of Exercise Compared With Baseline Maximum middle ear pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa Baseline and 2 months
Other Residual Middle Ear Pressure Observed During Maneuvers Following 2 Months of Exercise Compared With Baseline Residual middle ear pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa Baseline and 2 months
Other Eustachian Tube Function Observed During Maneuvers Following 2 Months of Rest Compared With Baseline Maximum middle ear pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa Baseline and 4 months
Other Residual Middle Ear Pressure Observed During Maneuvers Following 2 Months of Rest Compared With Baseline Residual middle ear pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa Baseline and 4 months
Other Eustachian Tube Function Observed During Maneuvers Following 2 Months of Rest Compared With Immediately Following 2 Months of Exercise Maximum middle ear pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa 2 months and 4 months
Other Residual Middle Ear Pressure Observed During Maneuvers Following 2 Months of Rest Compared With Immediately Following 2 Months of Exercise Residual middle ear pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa 2 months and 4 months
Other Velopharyngeal Function Observed During Maneuvers Following 2 Months of Exercise Compared With Baseline Maximum nasopharyngeal pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa Baseline and 2 months
Other Residual Nasopharyngeal Pressures Observed During Maneuvers Following 2 Months of Exercise Compared With Baseline Residual nasopharyngeal pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa Baseline and 2 months
Other Velopharyngeal Function Observed During Maneuvers Following 2 Months of Rest Compared With Baseline Maximum nasopharyngeal pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa Baseline and 4 months
Other Residual Nasopharyngeal Pressures Observed During Maneuvers Following 2 Months of Rest Compared With Baseline Residual nasopharyngeal pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa Baseline and 4 months
Other Velopharyngeal Function Observed During Maneuvers Following 2 Months of Rest Compared With Immediately Following 2 Months of Exercise Maximum nasopharyngeal pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa 2 months and 4 months
Other Residual Nasopharyngeal Pressures Observed During Maneuvers Following 2 Months of Rest Compared With Immediately Following 2 Months of Exercise Residual nasopharyngeal pressures achieved during Toynbee, Valsalva, Sniffing, Dive maneuver and the Patulous Test in daPa 2 months and 4 months
Primary Eustachian Tube Function at 2 Months Percent change in middle ear pressure equilibrated during the inflation-deflation test at 2 months 2 months
Secondary Eustachian Tube Function at 4 Months Percent change in middle ear pressure equilibrated during the inflation-deflation test at 4 months 4 months
See also
  Status Clinical Trial Phase
Completed NCT00340977 - Svangerskap, Arv, Og Miljo (Pregnancy, Heredity and Environment)
Completed NCT05166408 - Fistiulation Rate Following Primary Cleft Repair≤ N/A
Recruiting NCT03839290 - Development of the Palate in Bilateral Orofacial Cleft Newborns One Year After Early Neonatal Cheiloplasty
Recruiting NCT01867632 - Acellular Dermal Matrix in Primary Furlow Palatoplasty N/A
Completed NCT02900014 - Validation of a Production Method of Stem Cell Isolated From the Nasal Cavity for an Innovative Cell Therapy of Cleft Palate N/A
Withdrawn NCT02953145 - The Use of Fibrin Sealant to Reduce Post Operative Pain in Cleft Palate Surgery Phase 4
Completed NCT04725370 - Characterization of Cleft Lip and Palate Conditions in Guatemala
Withdrawn NCT03572907 - Use of Titanium Plate in Rhinoplasty in Patients With Cleft Lip and Palate : Aesthetic and Functional Impact.
Enrolling by invitation NCT02702869 - Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet)
Completed NCT02583100 - Improving Outcomes in Cleft Palate Surgery N/A
Recruiting NCT06072495 - Etiological Study of Persistent Velopharyngeal Insufficiency in Children With Operated Velopalatine Cleft by Analysis of Velopharyngeal Motor Skills in Static and Dynamic MRI N/A
Completed NCT04718558 - Optic Nerve Sheath Diameter Measurement in Cleft Palate Repair
Not yet recruiting NCT05357092 - Effects of AlignBabyCleft (ABaCleft) N/A
Completed NCT01500109 - Efficacy of Oral Versus Intravenous Acetaminophen for Primary Pediatric Cleft Palate Repair N/A
Completed NCT01252264 - FaceBase Biorepository
Completed NCT00397917 - Oral Cleft Prevention Program Phase 3
Enrolling by invitation NCT03632044 - Evaluation of Trigeminal Nerve Blockade Early Phase 1
Completed NCT04277273 - Characteristics of a Maxillofacial Prosthesis Consultation Within Assistance Publique - Hopitaux de Paris N/A
Completed NCT05405738 - Cleft Palate Technique and Maxillary Growth
Completed NCT03170505 - Using of Acellular Dermal Matrix in Cleft Palatal Fistula and Compare With Use of Conchal Cartolage N/A